Recent Quotes (30 days)

You have no recent quotes
chg | %

SQI Diagnostics Inc.  

(Public, CVE:SQD)   Watch this stock  
Find more results for SQD
+0.010 (5.56%)
Oct 26 - Close
CVE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 0.19 - 0.19
52 week 0.16 - 0.48
Open 0.19
Vol / Avg. 11,100.00/67,272.00
Mkt cap 16.77M
P/E     -
Div/yield     -
EPS -0.08
Shares 80.90M
Beta 1.38
Inst. own     -
Dec 14, 2016
Q4 2016 SQI Diagnostics Inc Earnings Release (Estimated) - 4:00PM EST - Add to calendar
Sep 12, 2016
SQI Diagnostics Inc at Rodman & Renshaw Global Investment Conference
Aug 18, 2016
Q3 2016 SQI Diagnostics Inc Earnings Release
Aug 18, 2016
Q3 2016 SQI Diagnostics Inc Earnings Call - Webcast

Key stats and ratios

Q2 (Jun '16) 2015
Net profit margin -615.32% -1376.30%
Operating margin -616.60% -1378.78%
EBITD margin - -1166.37%
Return on average assets -120.62% -131.16%
Return on average equity -317.11% -204.36%
Employees 33 -
CDP Score - -


36 Meteor Dr
+1-416-6749500 (Phone)
+1-416-6749300 (Fax)

Website links


SQI Diagnostics Inc. is a Canada-based life sciences company that develops and commercializes technologies and products for multiplexing diagnostics. The Company provides technology and equipment for blood testing in clinical trials and pre-clinical research for pharmaceutical and biotechnology companies. The Company applies its multiplexing technology to diagnostic tests used for customers in the animal health market, which includes companion and production animal tests for infectious diseases, food safety and other immunology tests. The Company also offers solutions for human diagnostic testing. The Company is also working on a pipeline of multiplexed in vitro diagnostics (IVD) products, which target protein and antibody biomarkers relevant to autoimmune and other immunological diseases. It offers detecting and quantifying proteins, antibodies and deoxyribonucleic acid (DNA). It offers assay development solutions. It offers sqidworks, sqidlite and sqid-X technologies.

Officers and directors

Andrew Morris President, Chief Executive Officer, Director
Patricia Lie Chief Financial Officer, Vice President of Finance and Administration
Catherine Smith Vice President - Technology
Jaymie R. Sawyer Vice President - Research & Development
Peter D. Winkley Chairman of the Board
Clive J. Beddoe Director
Age: 68
Gerald R. Connor Director
Age: 70
Wilmot L. Matthews Director
Age: 77
Cameron R. Prange Director
Allan Pronovost Ph.D. Director
Age: 56